✦ LIBER ✦

18. Expression of plasminogen activator inhibitor type 2 in invasive breast cancer

✍ Scribed by N. Fersis; U. Krainick; B. Schiffer; M.D. Kramer; G. Wittmann; G. Bastert

Book ID: 114316793
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 146 KB
Volume: 5
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(96)90078-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasminogen activator inhibitor type 2:

Plasminogen activator inhibitor type 2: expression and prognostic value in primary breast cancer

✍ N. Fersis; A. Ruja; Y.-L. Kuo; H. Friese; S. Thron; G. Bastert; D. Wallwiener 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Expression and prognostic value of plasm

Expression and prognostic value of plasminogen activator inhibitor type 1 in node-negative breast cancer

✍ Bin Wang; Ning Wang; Chunyan Xue; Bin Jiang; Yajie Wang 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 406 KB

Expression of urokinase-type plasminogen

Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and -2 in hepatocellular carcinoma

✍ Li Zhou; Yoshitake Hayashi; Takashi Itoh; Weiping Wang; Jing an Rui; Hiroshi Ito 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 575 KB

Expression and significance of urokinase

Expression and significance of urokinase-type plasminogen activator in breast cancer

✍ Xiao Jiping; Zhang Guangde; Xia Wenhua 📂 Article 📅 1999 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 247 KB

Urokinase and plasminogen activator inhi

Urokinase and plasminogen activator inhibitor type 2 in endometrial cancer

✍ N. Gleeson; R. Gonsalves; J. Bonnar 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 321 KB

Expression of urokinase-type plasminogen

Expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in colon disease

✍ Slobodan Miseljic; Susan Galandiuk; Stephen D. Myers; Dr. James L. Wittliff 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB 👁 1 views

Surveillance colonoscopy and biopsy are inaccurate methods of predicting the likelihood of ulcerative colitis patients to develop colon carcinoma. We examined uPA and PAI-1 as potential markers for assessing these patients and those with familial polyposis who are at risk of developing colon cancer.